Psychological and ethical issues relating to medication non-adherence in patients with chronic disease

• Authors: Helena van Oers
• Languages of publication: EN

Abstracts

EN

Treatment or medication non-adherence (MNA) is a far-reaching challenge to clinical practise that has a significant negative impact on treatment effectiveness and compromises the health and economic outcomes for both individuals and society. Lack of adherence to recommended therapeutic regimens reduces the effectiveness of treatment and may subsequently lead to disease progression, disabilities or death. Many studies have emphasized the magnitude of MNA and its effect on treatment outcomes, the patient’s health, on healthcare professionals and the associated costs. However, non-adherence is still common in clinical practice and no significant changes have been reported in recent years despite various research studies attempting to address and highlight the issue. MNA remains a major concern that is highly prevalent amongst medication-taking patients with chronic disease. Among the reported factors that may result in MNA practices are socioeconomic-related factors, factors related to the healthcare system, patient- or disease-related factors and treatment-related factors. The importance of ethical interventions cannot be understated and as such, MNA can be seen to be a multi-dimensional phenomenon which requires a far-reaching and multi-targeted solution. Several key areas in improving the rates of medication adherence are discussed and future foci in this area of research are identified.

Keywords

EN

adherence; chronic disease; ethics; medication; psychological

Discipline

• MEDICINE: MEDICINE

• Publisher: Scientific Publishing House „DARWIN”
• Journal: World News of Natural Sciences
• Year: 2025
• Volume: 60
• Pages: 280-288

Contributors

author

Helena van Oers

• Durban Oncology Centre, Durban, South Africa

References

• [1] World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, 2003.
• [2] Gruszczyńska M, Wyszomirska J, Daniel-Sielańczyk A, Bąk-Sosnowska M. Selected psychological predictors of medication adherence in the older adults with chronic diseases. Nursing Open 2020; 8: 317-326. https://doi.org/10.1002/nop2.632
• [3] Mir TH. Adherence Versus Compliance. HCA Healthc J Med. 2023, 2: 219-220. doi: 10.36518/2689-0216.1513
• [4] Bąk-Sosnowska M, Gruszczyńska M, Wyszomirska J, Daniel-Sielańczyk A. The Influence of Selected Psychological Factors on Medication Adherence in Patients with Chronic Diseases. Healthcare 2022; 10(3): 426. https://doi.org/10.3390/healthcare10030426
• [5] Moges TA, Dagnew SB, Wondm SA, Ferede YA, Yiblet TG, Almaw A et al. Determinants of medication non-adherence among patients with chronic diseases at community pharmacy settings in South Gondar Zone, Northwest Ethiopia: a multicentre cross-sectional study. Front. Public Health. 2024; 12: 12:1409153. https://doi.org/10.3389/fpubh.2024.1409153
• [6] Kleinsinger F. The Unmet Challenge of Medication Nonadherence. Perm J. 2018; 22: 18-033. doi: 10.7812/TPP/18-033
• [7] Burnier M. The role of adherence in patients with chronic diseases. Euro J Int Med. 2024; 119: 1-5. https://doi.org/10.1016/j.ejim.2023.07.008
• [8] Addo B, Sencherey S, Babayara MNK. Medication Noncompliance among Patients with Chronic Diseases Attending a Primary Health Facility in a Periurban District in Ghana. International Journal of Chronic Diseases. 2018; 7187284. https://doi.org/10.1155/2018/7187284
• [9] Oliviera CJ, Jose HMG, da Costa EIM. Medication Adherence in Adults with Chronic Diseases in Primary Healthcare: A Quality Improvement Project. Nurs. Rep. 2024; 14(3): 1735-1749. https://doi.org/10.3390/nursrep14030129
• [10] Pogany L, Lazary J. Health Control Beliefs and Attitude Toward Treatment in Psychiatric and Non-Psychiatric Clinical Samples. Front. Psychiatry 2021; 12, 537309. https://doi.org/10.3389/fpsyt.2021.537309
• [11] Stewart S-J, Moon Z, Horne R. Medication nonadherence: health impact, prevalence, correlates and interventions. Psychology & Health 2023; 38(6): 726-765. https://doi.org/10.1080/08870446.2022.2144923
• [12] Jayasree A, Shanmuganathan P, Alwar MC, Ramamurthy P. Types of Medication Non-adherence & Approaches to Enhance Medication Adherence in Mental Health Disorders: A Narrative Review. Indian J Psychol Med. 2024; 46(6): 503-510. https://doi.org/10.1177/02537176241233745
• [13] Livori AC, Dalli L, Nicholls SJ, Nelson AJ. Defining, measuring, and addressing medication non-adherence in cardiovascular disease. Future Cardiology 2024; 20(15-16); 819-822. https://doi.org/10.1080/14796678.2024.2433888
• [14] Gruszczyńska, M., Bąk-Sosnowska, M., & Szemik, S. Selected psychological aspects and medication adherence in oncological patients. Cancer Medicine 2020; 9(3), 943-950. https://doi.org/10.1002/cam4.2691
• [15] Dogonchi M, Mohammadzadeh F, Moshki M. Investigating the relationship between Health Locus of Control and health behaviors: A Systematic Review. Open Public Health Journal 2022; 15. https://doi.org/10.2174/18749445-v15-e2208010
• [16] Mozafari S, Yang A, Talaei-Khoei J. Health Locus of Control and medical behavioral interventions: Systematic review and recommendations. Interact J Med Res 2024; 13: e52287. doi: 10.2196/52287
• [17] Gerland H-M, Prell T. Association Between the Health Locus of Control and Medication Adherence: An Observational, Cross-Sectional Study in Primary Care. Front. Med. 2021;8: doi.org/10.3389/fmed.2021.705202
• [18] Nafradi L, Nakamoto K, Schulz PJ. Is patient empowerment the key to promote adherence? A systematic review of the relationship between self-efficacy, health locus of control and medication adherence. PLoS ONE 2017; 12(10). e0186458. https://doi.org/10.1371/journal.pone.0186458
• [19] Salarfard M, Moradi M, Abedian Z, Mazlum S R, Farkhani E M, Lotfi M. Relationship between health locus of control and treatment adherence in women with gestational diabetes. Journal of Mazandaran University of Medical Sciences 2020; 30(191): 115-120
• [20] Ifeagwazi CM, Adimaso DC, Onu D, Chinweze UC. Health locus of control, personality and social support in treatment adherence among diabetic patients. J Psychol in Africa 2023; 33(6), 618-624. DOI:10.1080/14330237.2023.2282271
• [21] Carey MP, Dunne EM, Norris A, Dunsiger S, Rich C, Rosen RK et al. Telephone-Delivered Mindfulness Training to Promote Medication Adherence and Reduce Sexual Risk Behavior Among Persons Living with HIV: An Exploratory Clinical Trial. AIDS Behav. 2020, 24, 1912-1928
• [22] Carrillo A, Belnap BH, Rothenberger SD, Feldman R, Rollman BL, Celano CM. Psychosocial predictors of health behavior adherence in heart-failure patients with comorbid depression: a secondary analysis of the Hopeful Heart trial. BMC Psychol. 2024; 12, 328. https://doi.org/10.1186/s40359-024-01816-4
• [23] Kvarnström K, Airaksinen M, Liira H. Barriers and facilitators to medication adherence: a qualitative study with general practitioners. BMJ Open 2016; 8(1): e015332. https://doi.org/10.1136/bmjopen-2016-015332
• [24] Crayton E, Fahey M, Ashworth M, Besser SJ, Weinman J, Wright AJ. Psychological Determinants of Medication Adherence in Stroke Survivors: a Systematic Review of Observational Studies. Annals of Behavioral Medicine 2017; 51(6): 833–845. https://doi.org/10.1007/s12160-017-9906-0
• [25] Venditti V, Bleve E, Morano S, Filardi T. Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites. 2023; 13(10): 1087. doi: 10.3390/metabo13101087
• [26] Rebić N, Law MR, Cragg J, Brotto LA, Ellis U, Garg R et al. What’s Sex and Gender Got to Do With It? A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence. Value in Health 2023; 26(9): 1413-1424. https://doi.org/10.1016/j.jval.2023.04.002
• [27] Vervloet M, Korrevaar JC, Leemrijse CJ, Paget J, Zullig LL, van Dijk L. Interventions to Improve Adherence to Cardiovascular Medication: What About Gender Differences? A Systematic Literature Review. Patient Preference and Adherence 2020;14:2055-2070
• [28] Theofilou P. Associated factors with adherence level of elderly patients with hypertension to the prescribed medication. The Open Public Health Journal 2022; 15. https://doi.org/10.2174/18749445-v15-e221220-2022-136
• [29] Lee E, Choi M. Factors associated with medication adherence among older adults with multimorbidity: A culture perspective. Geriatric Nursing 2024; 55: 297-303. https://doi.org/10.1016/j.gerinurse.2023.11.018
• [30] Al-Noumani H, Alharrasi M, Lazarus ER, Panchatcharam SM. Factors predicting medication adherence among Omani patients with chronic diseases through a multicenter cross-sectional study. Sci Rep. 2023; 13, 7067. https://doi.org/10.1038/s41598-023-34393-4
• [31] Bernardini J. Ethical issues of compliance/adherence in the treatment of hypertension. Advances in Chronic Kidney Disease 2004; 11(2): 222-227
• [32] Yfantopoulos J, Protopapa M, Chantzaras A, Yfantopoulos P. Doctors’ views and strategies to improve patients’ adherence to medication. Hormones 2021; 20: 603-611. https://doi.org/10.1007/s42000-021-00294-2

• Document Type: article